Miss. High Court Tosses $2M Risperdal Verdict Against J&J

Law360, New York (October 20, 2017, 5:19 PM EDT) -- The Mississippi Supreme Court on Thursday tossed a $1.95 million verdict in a lawsuit against Johnson & Johnson and its subsidiary over a movement disorder allegedly caused by its antipsychotic drug Risperdal, saying the drug's label sufficiently warned about the drug's associated risks.

The court reversed the judgment that Risperdal contained inadequate warnings about the risk of developing the movement disorder tardive dyskinesia and ordered a new trial over the allegation that Ortho-McNeil Janssen Pharmaceuticals misrepresented the treatment to a physician, because the jury instructions didn't fully explain the elements of a negligent misrepresentation claim.

"Here, the Risperdal label unequivocally communicated...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!